Monthly Cost Breakdown: Wegovy vs Mounjaro Pricing
Wegovy and Mounjaro Monthly Cost Structure in the UK
Understanding the monthly costs for Wegovy and Mounjaro requires examining each treatment's dose escalation schedule and maintenance pricing. Both prescription-only medicines follow structured dosing protocols that affect monthly expenses throughout your treatment journey. Wegovy begins at £79.99 for the 0.25mg starter dose, progressing through £94.99 (0.5mg), £99.99 (1mg), and £139.99 (1.7mg) before reaching the maintenance dose of 2.4mg at £209.99 monthly. This escalation occurs over 16 weeks, allowing patients to budget accordingly for each phase.
Mounjaro follows a different escalation pattern with its own pricing structure, making direct monthly comparisons essential for treatment planning. Both Wegovy and Mounjaro are available from EverydayMeds, and your prescriber can help determine which option provides better value for your specific clinical needs. The key difference lies not just in monthly costs but in the duration of each dose phase and long-term maintenance requirements. Consider that maintenance dosing represents the majority of your treatment costs, making the monthly maintenance price particularly important for annual budgeting.
Wegovy and Mounjaro Pricing: Bundle Savings and Discount Codes
EverydayMeds offers strategic bundle pricing for both Wegovy and Mounjaro to help manage monthly costs effectively. Our Intro Duo bundle (0.25mg & 0.5mg Wegovy) costs £169.99, covering your first two months of treatment with convenient single delivery. The Progress Trio bundle (0.5mg, 1mg & 1.7mg) at £369.99 provides three months of mid-escalation supply, whilst our Ultimate Stability Trio delivers three months of 2.4mg maintenance doses for £649.99. New customers apply code FIRST40 at checkout, whilst returning customers use DOSE25 to maintain competitive pricing.
These bundles provide convenience and supply security rather than pure cost savings, ensuring you maintain treatment continuity without multiple orders. The monthly cost predictability becomes particularly valuable during maintenance therapy, where the 2.4mg dose represents your ongoing expense. Both Wegovy and Mounjaro bundle options help smooth the financial commitment across treatment phases, making budgeting more manageable for long-term weight management therapy.
Clinical Evidence Supporting Wegovy and Mounjaro Investment
The monthly costs for Wegovy and Mounjaro reflect the substantial clinical evidence supporting these treatments' effectiveness. In the STEP trials, patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The STEP 5 trial demonstrated sustained weight loss of approximately 15.2% at two years, supporting the value proposition of continued monthly investment in treatment.
Mounjaro's clinical trials show similar effectiveness patterns, though direct comparison of trial percentages isn't appropriate due to different study designs and patient populations. Both treatments represent significant monthly financial commitments, but the clinical evidence suggests potential long-term health benefits that may justify the ongoing costs. Your prescriber can discuss how the clinical evidence applies to your individual situation when considering monthly treatment expenses.
How Wegovy and Mounjaro Work: Understanding Your Monthly Investment
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics natural fullness hormones to reduce appetite and promote satiety after smaller meals. This mechanism may help reduce food cravings by working on brain appetite centres, potentially leading to sustained dietary changes that support your monthly treatment investment. Mounjaro contains tirzepatide, which targets both GLP-1 and GIP receptors, offering a dual mechanism approach to appetite regulation. Both treatments require once-weekly injections using pre-filled FlexTouch pens, making the monthly cost calculation straightforward based on weekly dosing. The biological mechanisms justify the prescription-only medicine status and associated monthly costs through their targeted approach to weight management.
Ordering Process for Wegovy and Mounjaro Monthly Supply
Accessing monthly supplies of Wegovy and Mounjaro through EverydayMeds involves a streamlined three-minute online clinical assessment covering your medical history and treatment suitability. Our qualified prescribers review applications within three working days (or 24 hours with express service), ensuring appropriate clinical oversight for these prescription-only medicines. Once approved, next-day delivery ensures rapid treatment commencement, with cold-chain temperature-controlled packaging maintaining medication integrity. Monthly reordering becomes simple through your patient account, with reminder systems helping maintain treatment continuity. The GPhC-registered pharmacy credentials (#9012878) provide confidence in medication authenticity and clinical governance throughout your treatment journey.
Storage and Practical Considerations for Wegovy and Mounjaro
Both Wegovy and Mounjaro require refrigerated storage at 2-8°C before first use, with important differences affecting monthly planning and travel considerations. Wegovy pens can remain at room temperature (below 30°C) for up to six weeks once removed from refrigeration, whilst Mounjaro allows only 21 days at room temperature. This storage advantage makes Wegovy more suitable for frequent travellers who may struggle with refrigeration access during monthly treatment cycles. The FlexTouch pen system for both medications provides consistent dosing throughout the monthly supply, with clear dose escalation schedules preventing confusion during treatment progression. Monthly pen replacement ensures optimal medication potency and injection reliability throughout your treatment course.
Long-term Budgeting for Wegovy and Mounjaro Monthly Costs
Planning annual budgets for Wegovy and Mounjaro requires understanding that maintenance dosing represents the majority of treatment costs once escalation completes. At £209.99 monthly for Wegovy 2.4mg maintenance doses, annual costs reach approximately £2,519.88, excluding any bundle savings or promotional pricing. The DOSE25 returning customer code helps maintain competitive pricing for ongoing monthly supplies, making long-term budgeting more predictable. Consider that weight regain may occur if treatment stops, with STEP trial extensions showing patients regained approximately two-thirds of lost weight within one year of discontinuation.
This evidence suggests that viewing Wegovy and Mounjaro as long-term monthly investments rather than short-term solutions provides more realistic cost planning. Both treatments work alongside reduced-calorie diets and increased physical activity, meaning monthly medication costs should be considered alongside lifestyle modification expenses. The monthly cost commitment becomes more manageable when viewed as ongoing healthcare investment rather than temporary treatment expense.
EverydayMeds Advantage for Wegovy and Mounjaro Monthly Supply
EverydayMeds provides competitive monthly pricing for both Wegovy and Mounjaro with transparent cost structures and reliable supply chains ensuring treatment continuity. Our clinical team reviews each prescription application individually, ensuring appropriate treatment selection between these options based on your medical history and treatment goals. The combination of FIRST40 new customer savings and DOSE25 returning customer benefits provides ongoing value for monthly treatment costs. Visit https://everydaymeds.co.uk/collections/wegovy to start your clinical assessment and access competitive monthly pricing for both treatment options. Remember that both Wegovy and Mounjaro are available from EverydayMeds, and your prescriber can help determine which option offers the best value for your individual circumstances and monthly budget considerations.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
